menu
    • menu

    Company profile for Opus Genetics

    NEW Drugs in Dev: 10
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Guizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Opus Genetics is a patient-first, science driven gene therapy company tackling manufacturing obstacles standing in the way of treatments for ultra-rare blinding conditions.Opus Genetics is a groundbreaking gene therapy company for inherited retinal diseases with a unique model and purpose. Backed by Foundation Fighting Blindness’s venture arm, the RD Fund, Opus combines unparalleled insight and commitment to patient need wit...
    Opus Genetics is a patient-first, science driven gene therapy company tackling manufacturing obstacles standing in the way of treatments for ultra-rare blinding conditions.Opus Genetics is a groundbreaking gene therapy company for inherited retinal diseases with a unique model and purpose. Backed by Foundation Fighting Blindness’s venture arm, the RD Fund, Opus combines unparalleled insight and commitment to patient need with wholly owned programs in numerous orphan retinal diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Opus GeneticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    37000 Grand River Avenue, Suite 120, Farmington Hills, MI 48335
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://opusgtx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/opus-genetics/?viewAsMember=true
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/OpusGenetics

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    PBP World Meeting

    Not Confirmed

    envelop Contact Supplier

    PBP World Meeting

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Opus Genetics Reveals 2025 Financials, Updates Corporate Status
    Opus Genetics Reveals 2025 Financials, Updates Corporate Status

    10 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/10/3252597/0/en/Opus-Genetics-Announces-Financial-Results-for-Full-Year-2025-and-Provides-Corporate-Update.html

    GLOBENEWSWIRE
    10 Mar 2026
    Share Share
    Opus Genetics To Present At Investor Conferences In March 2026
    Opus Genetics To Present At Investor Conferences In March 2026

    03 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/03/3248271/0/en/Opus-Genetics-to-Present-at-Upcoming-Investor-Conferences-in-March-2026.html

    GLOBENEWSWIRE
    03 Mar 2026
    Share Share
    Opus Genetics Unveils Phase 1/2 OPGX-BEST1 Gene Therapy Data
    Opus Genetics Unveils Phase 1/2 OPGX-BEST1 Gene Therapy Data

    27 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/27/3246599/0/en/Opus-Genetics-Announces-Initial-Clinical-Data-from-Phase-1-2-OPGx-BEST1-Gene-Therapy-Study-at-the-Macula-Society-Annual-Meeting.html

    GLOBENEWSWIRE
    27 Feb 2026
    Share Share
    FDA Accepts Opus Genetics' sNDA for 0.75% Phentolamine
    FDA Accepts Opus Genetics' sNDA for 0.75% Phentolamine

    25 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/25/3244435/0/en/Opus-Genetics-Announces-FDA-Acceptance-of-Supplemental-New-Drug-Application-for-Phentolamine-Ophthalmic-Solution-0-75-for-the-Treatment-of-Presbyopia.html

    GLOBENEWSWIRE
    25 Feb 2026
    Share Share
    Opus Genetics Announces $25 Million Private Placement
    Opus Genetics Announces $25 Million Private Placement

    13 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/13/3238035/0/en/Opus-Genetics-Announces-25-Million-Private-Placement.html

    GLOBENEWSWIRE
    13 Feb 2026
    Share Share
    Opus Genetics to Attend Feb. 2026 Medical & Industry Conferences
    Opus Genetics to Attend Feb. 2026 Medical & Industry Conferences

    02 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/02/3230181/0/en/Opus-Genetics-to-Participate-in-Upcoming-Medical-and-Industry-Conferences-in-February-2026.html

    GLOBENEWSWIRE
    02 Feb 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search